Deficiency of lysosomal acid lipase (LAL) (33) is associated with Lysosomal acid lipase (LAL) activity was measured using a new fluorometric assay in cultured skin fibroblasts from eight control subjects, two obligate heterozygotes for Wolman's disease (WD), one patient with WD, and one patient with cholesteryl ester storage disease (CESD). The LAL activities (mean * S D ) were 25.8 + 8.2, 13.2 =t 0.1, 1.1, and 1.4 nmol4-methylumbelliferyl oleate (4-MUO) hydrolyzed/min/mg protein, respectively. These results compare favorably with those obtained using standard radioassays. The LAL activities of two cultures of amniotic fluid cells were 12.1 and 10.5. The LAL activity (mean S D ) of peripheral leukocytes obtained from 34 laboratory volunteers (19 females, 15 males) was 4.0 * 1.8.
Extract
Deficiency of lysosomal acid lipase (LAL) (33) is associated with Lysosomal acid lipase (LAL) activity was measured using a new fluorometric assay in cultured skin fibroblasts from eight control subjects, two obligate heterozygotes for Wolman's disease (WD), one patient with WD, and one patient with cholesteryl ester storage disease (CESD). The LAL activities (mean * Partially purified lymphocytes contained about 25 times as much LAL activity as did granulocytes. Cellogel electrophoresis, followed by staining with CMUO, showed a t least two bands of LAL (A and B) from normal fibroblasts, amniotic fluid cells, and lymphocytes. Band A was absent from WD and CESD fibroblasts and was reduced in fibroblasts of the WD heterozygotes.
Speculation
Deficiency of lysosomal acid lipase activity is associated with lysosomal accumulation of cholesteryl esters and triglycerides. One of the early events in atherogenesis is the accumulation of cholesteryl esters in the lysosomes of arterial smooth muscle cells. Genetic variants of lysosomal acid lipase, resulting in reduced activity or altered catalytic properties, may be predisposing factors in the development of premature atherosclerosis. a wide spectium of clinical disease in man, ranging from the fatal infantile form of Wolman's disease (WD) to the relatively benign disorder, cholesteryl ester storage disease (CESD). There have been some 35 cases of WD, its clinical variants, and CESD reported in the literature since 1956 (19, 25) . Table 1 summarizes the cases from 1971 to the present. Deficiency of LAL in these diseases results in massive lysosomal accumulation of neutral fats, chiefly cholesteryl esters and triglycerides, in the cells of a variety of tissues (9) . The acute infantile form of WD is usually fatal within 6 months of life. Variants of WD with later onset and longer survival have been reported (19) . Other variants of WD, as well as CESD, are apparently clinically benign conditions. The reported patients are still alive, with the exception of female twins (10) who died of unrelated causes.
In this report, we present an additional case of WD with details of procedures for the quantitative assay and electrophoresis of LAL in fibroblasts of this patient, her parents, and a patient with CESD.
CASE REPORT
AJ was an apparently normal newborn girl delivered uneventfully to a healthy gravida I, para 0,20-year-old Caucasian woman and her 26-year-old unrelated Caucasian husband. The family history was unremarkable. The patient was well until 8 weeks of age when abdominal distention was noted. She continued to appear alert and well except for increasing abdominal distention until her first hospital admission (October 28, 1971) at 10 weeks of age. On physical examination, her height was at the 50th percentile, her weight and head circumference at the 8th percentile. Abdominal distention was in part due to the presence of ascites and there was enlargement of the liver, palpable 6 cm below the right costal margin, and the spleen, 4 cm below the left. Serum cholesterol ranged from 123-17 1 mg/ 100 ml and serum triglycerides ranged from 148-232 mg/100 ml. Lipoprotein electrophoresis showed 5% a-, 21% pre-@-, and 74% P-lipoprotein. Initial liver function studies were normal. Serum cortisol was in the normal range.
X-ray (flat plate) studies and intravenous pyelography revealed massive bilateral adrenal calcification. Vacuoles were observed in peripheral blood lymphocytes and bone marrow. The findings suggested Wolman's disease. The child's condition progressively deteriorated over the next 2 months; she developed severe anemia, thrombocytopenia, progressive hepatosplenomegaly, generalized edema, and jaundice. She died at 19 weeks of age in cardiorespiratory arrest.
PATHOLOGIC REPORT
The body was that of a 4-month-old female, weighing 5,222 gm and measuring 60 cm in crown-heel length. There was generalized edema, abdominal distention, and jaundice. Fifty milliliters of ascitic fluid were present. Minimal left ventricular hypertrophy was present. The liver was massively enlarged (528 g; 160 g normal), bright yellow, and firm. The spleen was also massively enlarged (267 g; 16 g normal), and of normal color. Lymph nodes throughout the body were enlarged, bright yellow, and firm. The adrenals were symmetrically enlarged (right 15 g, left 19 g; normal combined weight 15 g), very firm, and bright yellow. Calcifications were observed on the cut surfaces in the deep cortical areas. The kidneys were somewhat enlarged symmetrically (61 g; 53 g normal). Yellowish mottling of the cortex and the papillae was observed. The costochondral junctions were yellowish and the spinal ganglia were enlarged and yellowish.
On microscopic examination, "foam" cells were found in the pulmonary alveoli and interstitium, the duodenal mucosa, the mesenteric adipose tissue, throughout the liver, and within the thymus, spleen, lymph nodes, bone marrow, and adrenals. The liver showed fine fibrosis and focal canalicular bile stasis. The peripheral fetal cortex of both adrenals was calcified.
Frozen sections of formalin-fixed tissue revealed abundant Oil Red 0-positive material in the foam cells of all tissues, and also in cells not recognizably "foamy," including bronchial cartilage and epithelium, arterial walls, hepatic parenchyma and biliary epithelium, macrophages and/or round cells in the gut and kidney, and throughout the adrenal cortex.
Lipid 
MATERIALS AND METHODS

FIBROBLAST CULTURES
Skin biopsies were obtained from the patient at 11 weeks of age and from both her parents using an electric rotating punch drill. Cultured fibroblast cells from a patient with cholesteryl ester storage disease (LMc, References 10 and 26) were obtained from Dr. H. R. Sloan.
Skin biopsies from five infants (four male, one female) and three adults (two male, one female), all apparently healthy, were obtained as controls. Amniotic fluid cells were cultured from two fetuses. All cells were grown in Ham's FIO medium supplemented with 15% fetal calf serum (34).
Cultures were maintained in roller bottles (490 cmZ growth area, Reference 35) and fed regularly twice weekly. All cells used in enzymatic assays, electrophoresis, and Oil Red 0 staining were derived from the 5th to 12th subcultures, harvested early after confluence.
OIL RED 0 STAINING
Fibroblasts were grown on cover slips in Leighton tubes. After a monolayer developed, the medium was removed, the cells were washed in normal saline, and fixed in 10% formalin. After 10 min in 50% pyridine, slides were stained for 30 min in 4% Oil Red 0 in 70% pyridine, destained for 3-5 min in 50% pyridine, and counterstained for 90 sec in aqueous hematoxylin.
PREPARATION OF FIBROBLASTS FOR ENZYME ASSAY AND ELECTROPHORESIS
Cells grown in roller bottles were harvested by trypsinization, washed three times in normal saline, and suspended in 5-10 volumes of distilled water. They were sonicated in an ice bath for 30 sec at 30 W with a Branson Sonifier (36) and centrifuged at 40,000 x g for 30 min at 4'. The supernatant was stored at -65' until assayed. Tri-Carb liquid scintillation counter (43) . Quench correction was
PREPARATION OF LEUKOCYTES
Peripheral leukocytes were obtained from fresh, heparinized venous blood, either as buffy coat preparations or after dextran sedimentation (3). Purified lymphocytes and granulocytes were obtained by centrifugation in Lymphoprep (37) by the method of Boyum (4) . Cell pellets were freed of erythrocytes by hypotonic lysis, and then sonicated and centrifuged as described above for fibroblasts.
ASSAY OF LYSOSOMAL AClD LIPASE ACTIVITY
Fluorometric Assay. One milliliter of M 4-methylumbelliferyl oleate (4-MUO, Reference 38) in hexane and one ml of 16 mM L-a-phosphatidylcholine (egg yolk lecithin, Reference 39) in hexane were evaporated together to dryness under a stream of nitrogen, resuspended in 25 ml of 2.4 mM sodium taurocholate (40) and sonicated (36) in an ice bath at 50 W for I min. The substrate appeared to be a very fine homogeneous dispersion, and was stable for periods up to 4 days. At the time of assay, I volume was added to 7 volumes of 0.2 M acetate buffer, pH 4.0. Each 2. 0-1111 reaction vessel contained 0.1 pmol 4-MUO, 0.16 lrmol lecithin, and 0.6 pmol sodium taurocholate. Enzyme source (5-50 pl) was added to initiate the reaction and the change in relative fluorescence was recorded over 2-5 min at 37" usinn an Arnincoachieved by the automatic external standards method. Counting efficiency was approximately 85%. Results were expressed as picomoles of free fatty acid liberated per hr per mg protein.
Protein Determination. Protein concentration was measured by the method of Lowry et al. (17) .
CELLOGEL ELECTROPHORESIS
Electrophoresis in Cellogel (44) was carried out using 0.25 M barbital-HCI buffer, pH 8.6, for 3 hr at 4O and 250 V or 0.03 M phosphate-0.01 M citric acid, pH 6.3, for 3 hr at room temperature and 150 V, using 5-50 pl (I -150 pg protein) of enzyme source. Gels were stained for LAL activity using 4-methylumbelliferyl oleate, prepared according to the method of fluorornetric assay described above. After prerinsing for 1 min in 0.2 M acetate buffer, pH 4.0, gels were stained for 5 rnin. Excess stain was decanted and the gels 'were incubated at 37O and viewed periodically under long wave ultraviolet illumination until bands of LAL appeared. Figure I demonstrates the massive accumulation of Oil Red 0-positive material in WD fibroblasts. There was no such accumulation seen in heterozygote or control cells. Bowman spectrophotofluorometer (41) at an exitation wave length of 335 nm, and an emission wave length of 455 nm. Blanks
RESULTS
OIL RED 0 STAINING
LAL ACTIVITY IN FIBROBLASTS AND LEUKOCYTES
consisted of either substrate and buffer alone or substrate and Table 2 summarizes the LAL activities of fibroblasts, using buffer plus enzyme source heated to 80' for 10 min. In either case, 4-MUO, triolein (glyceryl trioleate), and cholesteryl oleate as substrates. With 4-MUO, both WD and CESD cells had less than 10% of control levels of LAL activity, and heterozygotes had about 50%. These results compare favorably with those seen using the radioactive substrates. The activities of two lines obtained from cultures of amniotic fluid cells were 12.1 and 10.5, respectively, using 4 -M U 0 as substrate.
Peripheral leukocytes obtained from 34 laboratory volunteers (19 females, 15 males) showed considerable variation in LAL activity when measured using 4-MUO. The sample mean activity ( A D ) was 4.0 + 1.8. When blood samples from three individuals were sedimented in Lymphoprep, the lymphocytes contained 19.8 * 2.3 U LAL activity and granulocytes contained 0.8 * 0.3 U.
Sonication of fibroblasts, amniotic fluid cells, and leukocytes was found to release significantly more LAL activity than did freezing and thawing. Figure 2 shows the results of electrophoresis of fibroblast extracts and staining for LAL using 4-MUO. Lane 3 is a control line, with at least three bands, labeled A, B, and C. The least anodal band, A, was the most prominent one in controls but was reduced in heterozygotes (lane 2) and was undetectable in both WD and CESD (lanes I and 4, respectively). Band B was present in cells from all individuals tested. Band C was present in some, but not all samples. It could often be detected only when 5-10-fold concentrations of samples were applied to gels. Band A, on the other hand, was never seen in WD and CESD cells, even when highly concentrated (15-fold) samples were applied.
CELLOGEL ELECTROPHORESIS OF LAL
Cultured amniotic fluid cells from normal fetuses showed the same bands, but with reduced intensity, as the normal adult fibroblasts. Leukocytes, and especially lymphocytes (Fig. 3) , contained both bands A and B, but no LAL activity could be seen in granulocytes. Lymphocytes were electrophoretically indistinguishable from normal fibroblasts. Similarly, tissues obtained at autopsy from individuals not affected with WD (liver, spleen, lymph nodes, aorta) showed bands A and B. LAL could not be detected in serum.
DISCUSSION
Marked deficiency of lysosomal acid lipase in man is associated with considerable clinical variability. Although slightly more activity is measured in CESD cells than in WD cells, this does not readily explain the striking difference in the clinical course of the two diseases. They may result from the same mutation, and some other factor(s) may protect patients with CESD from the profound disease seen in WD. It is of interest to note the occurrence (19) in one family of two siblings with LAL deficiency. One was a child with all the classic features of WD, except for slightly later onset (4 months) and longer survival (death at 14 months), and the other was a young sibling whose first hospital admission was at 12 months. Except for continuing bouts of diarrhea and the appearance of abdominal distention, the child was reported well at 4.5 years.
WD and CESD may be expressions of different mutations at the same or different loci. If so, then WD and CESD cells should readily complement one another when heterokaryons of the two are made by cell fusion (23, 28) .
Apart from the striking difference in clinical course of the two diseases, other distinctions have been made. Fredrickson et al. (10) have found that the lipolytic activities of both WD and CESD tissues toward most esters were virtually absent but a CESD liver had nearly normal activity towards hexadecanyl-l,2-dioleate, whereas a WD liver had no activity. Assman et al.
(1) compared the types of cholesteryl esters stored in WD and CESD tissues and found that WD tissues (including those from patient AJ) had excessive storage of oxygenated steryl esters. This was not seen in the patient ( L M c ) with CESD.
Despite considerable variation in LAL activity among fibroblasts of the eight healthy control subjects that we tested, we observed no overlap between the normal and heterozygote levels of LAL. All eight cell lines had identical electrophoresis patterns.
Our observation that heterozygotes have about 50% of control LAL activity is consistent with some published results (13, 19) but not with others (20) . Heterozygotes for CESD have been shown to have intermediate levels of LAL activity (2) .
Electrophoresis of LAL shows absence, of band A from both WD and CESD cells and considerably reduced band A in the heterozygotes, when compared with controls. The residual ( < 10%) activity measured in WD and CESD is probably due to the B isozyme. The relationships among bands A, B, and C are unclear, although some preliminary results suggest that B differs from A in molecular weight and substrate specificity.
LAL activity in amniotic fluid cells can be measured and its electrophoretic pattern is the same as that seen from cultured skin fibroblasts, allowing the prenatal diagnosis of WD to be made. The successful prenatal diagnosis of WD has been recently reported The findings in normal white cells, particularly lymphocytes, of LAL activity and reproducible isozyme patterns by electrophoresis make it possible to survey a population for variants of LAL. WD is a rare disorder, apparently no more prevalent in one ethnic group than another, and therefore screening the general population for WD heterozygotes would be impractical. Nevertheless, the availability of these methods permits the analysis of genetic variation at the LAL locus.
One consequence of genetic variation of LAL is potentially of great importance. During the development of atherosclerosis, cholestervl esters accumulate within lvsosomes of arterial smooth muscle cdlls (1 1, 2 I), and DeDuve (8) has suggested that this could result from the relative deficiency of LAL. Indeed, one patient with CESD who died at age 21 of causes apparently unrelated to LAL deficiency showed an extraordinary degree of atherosclerosis for her age (10) . Furthermore, all WD patients in whom postmortem examination of the arteries was made showed some degree of fat accumulation (7, 15, 16, 18, (29) (30) (31) , and present case). It is possible that genetic variants of LAL can be found with reduced or altered hydrolytic activity toward cholesteryl esters. Individuals with these variants may be at increased risk of developing premature atherosclerosis, especially when challenged by high circulating levels of serum lipids.
The recent work of Brown and Goldstein (5) has defined the metabolic problem present in familial hypercholesterolemia, an inherited disorder known to predispose to premature atherosclerosis. In this condition there is defective synthesis of low density lipoprotein (LDL) receptors indirectly reiulting in massive accumulation of intracellular (but not intralvsosomal~ cholesterol. LAL activity in the fibroblaits from patienis who are homozygous or heterozygous for this disorder has been inferred to be normal.
S U M M A R Y leukocytes, and in tissues obtained at autopsy. These studies suggest that populations can be screened for genetic variants of LAL and such variants may be associated with premature atherosclerosis.
